Critpime TZ 1.125 Injection
Marketer
Fibovil Pharmaceuticals Pvt Ltd
Salt Composition
Cefepime (1000mg) + Tazobactum (125mg)
Overview Critpime TZ 1.125 Injection
Tazicef 1.125mg Injection combines two antibiotics to combat diverse bacterial infections by hindering microbial proliferation. Administration must be overseen by a healthcare provider. Complete the prescribed dosage, even with symptom improvement; missed doses should be avoided. Common side effects include nausea, vomiting, diarrhea, and skin rashes. Injection site reactions (redness, swelling, pain) may occur but typically resolve. Worsening side effects necessitate immediate medical attention. Seek immediate help for allergic reactions (rashes, itching, swelling, breathing difficulties). Inform your doctor about all medications before use, especially if pregnant or breastfeeding. Alcohol consumption should be avoided due to potential increased drowsiness. While generally not impairing driving ability, avoid driving if drowsiness or dizziness occurs.
Uses of Critpime TZ 1.125 Injection
Infections caused by bacteria
Major Benefits of Critpime TZ 1.125 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Critpime TZ 1.125 Injection:
- Diarrhea
- Increased white blood cell count (eosinophils)
- Injection site phlebitis
- Skin rash
- Increased liver enzymes
- Positive Coombs test
How to use Critpime TZ 1.125 Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Critpime TZ 1.125 Injection works:
Critpime TZ 1.125 Injection merges Cefepime, an antibiotic, with Tazobactum, a beta-lactamase inhibitor. Cefepime combats bacteria by disrupting their protective outer layer, crucial for their viability. Tazobactum counteracts bacterial enzymes that would otherwise neutralize Cefepime, thus broadening Cefepime's effectiveness and overcoming bacterial resistance.
SAFETY ADVICE
AlcoholCAUTION
Using Critpime TZ 1.125 Injection with alcohol requires careful consideration. Seek medical advice before combining them.
PregnancySAFE IF PRESCRIBED
The injectable medication Critpime TZ 1.125 is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nonetheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
The injectable medication Critpime TZ 1.125 is considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer to breast milk, posing no apparent risk to the infant.
DrivingUNSAFE
Following administration of Critpime TZ 1.125 Injection, temporary blurred vision may occur. Refrain from driving until visual acuity returns to normal.
KidneyCAUTION
Patients with kidney impairment should use Critpime TZ 1.125 Injection cautiously, as dose modification may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Critpime TZ 1.125 Injection in patients with hepatic impairment is likely safe. Existing evidence indicates that dose modification may be unnecessary; however, physician consultation is advised.
What if you forget to take Critpime TZ 1.125 Injection :
Omit a scheduled dose of Critpime TZ 1.125 Injection? Seek medical advice immediately.
Facts to Know About Critpime TZ 1.125 Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-infective agents |
3,018 People bought this recently